Animal eggs not suitable substitutes to produce stem cells – Since the cloning of Dolly the Sheep over a decade ago, somatic cell nuclear transfer (SCNT) has been considered a promising way to generate human, patient-specific stem cells for therapeutic applications.
Geron Receives FDA Clearance to Begin World’s First Human Clinical Trial of Embryonic Stem Cell-Based Therapy. Geron to Study GRNOPC1 in Patients with Acute Spinal Cord Injury. – Geron Corporation (Nasdaq: GERN) announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company’s Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.
All NIH human embryonic stem cell registry lines now deposited at NSCB – The U.S. National Stem Cell Bank (NSCB) has announced that it has received deposits of two human embryonic stem cell lines from Cellartis AB, a biotechnology company based in Sweden. With the addition of the new lines, the National Stem Cell Bank now has received all 21 cell lines from the six providers listed on the National Institutes of Health (NIH) federal registry.
Scientists call up stem cell troops to repair the body using new drug combinations – Scientists have tricked bone marrow into releasing extra adult stem cells into the bloodstream, a technique that they hope could one day be used to repair heart damage or mend a broken bone, in a new study published today in the journal Cell Stem Cell.
USC researchers derive first embryonic stem cells from rats. Finding represents major breakthrough for biomedical research. – Researchers at the University of Southern California (USC) have, for the first time in history, derived authentic embryonic stem (ES) cells from rats. This breakthrough finding will enable scientists to create far more effective animal models for the study of a range of human diseases.
The International Society for Stem Cell Research releases new guidelines. Regulation needed as new study reveals clinics exaggerate claims and omit risks. – The International Society for Stem Cell Research (ISSCR), the world’s leading professional organization of stem cell researchers, released new guidelines for the responsible development of safe and effective stem cell therapies for patients.
The researchers replaced the left main bronchus of a 30-year-old woman with a specially prepared cadaveric trachea and successfully avoided left pneumonectomy. – The first operation for transplantation of a tissue-engineered airway has been successful. This procedure has massively improved the quality of life of the 30-year-old Colombian female recipient who needed the transplant after contracting tuberculosis.
Biotechnology Industry Organization (BIO) welcomes advances in stem cell research, and stresses continued importance of pursuing all promising areas of research. – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the news that researchers at the Harvard Stem Cell Institute created 20 disease-specific stem cell lines thru the new induced pluripotent stem cell (iPS) technique:
An Australian man who was paralysed by a rugby injury has reportedly made dramatic steps towards recovery after receiving injections of embryonic stem cells from an Indian doctor Geeta Shroff in New Delhi. – An amazing recovery noticed in an Australian Perry Cross who is quadriplegic, after regular injections of embryonic stem cells. Perry Cross was a rugby player and he got the paralysis of all his limbs in 1994 when he was 19 years old. Since then he was on ventilator to breath.
Researchers are hoping to develop the first treatment for broken bones using a patient’s own stem cells. – Scientists are developing a revolutionary way to mend damaged bones and cartilage using a patient’s own stem cells.